medline.ch Onkologie Urologische Tumoren

	Conventional vs. Hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT. Radiother Oncol Martínez C, Tisseverasinghe S, Karim MU, Ka K, Nabid A, Kaldany E, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M, Niazi T. PMID: 41905637 [PubMed - as supplied by publisher]
	From complexity to clarity: GPT-4 for patient-centered prostate cancer pathology reports. Patient Educ Couns Fereydooni S, Homer R, Chartash D. PMID: 41905268 [PubMed - as supplied by publisher]
	Association between pioglitazone use and prostate cancer in patients with type 2 diabetes: A retrospective cohort study. Cancer Epidemiol Lai SW, Liao KF. PMID: 41905181 [PubMed - as supplied by publisher]
	Moderate Hypofractionated Helical Tomotherapy for Localized Prostate Cancer in Older Patients: A Single-Institution Study of Toxicity and Outcomes. Technol Cancer Res Treat Meng L, Di Y, Ma L, Qu B. PMID: 41904699 [PubMed - indexed for MEDLINE]
	The identification of clinicopathological features predictive of recurrence following lymphadenectomy in penile cancer: A systematic review. Urol Oncol Garaz R, Peri J, Mirvald C, Muneer A, Alnajjar HM, Rausch S, Thomas A, Surcel C, Crozier J, Niyazi M, Haddad H, Tsaur I. PMID: 41904097 [PubMed - as supplied by publisher]
	Beyond clear cell: Rare histologic and molecular variants of renal cell carcinoma. Urol Oncol Moradi A, Fann J, Zhang G, Pal SK, Sadimin E. PMID: 41904096 [PubMed - as supplied by publisher]
	Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study. J Am Soc Cytopathol Kleinjan ML, Antic T. PMID: 41904061 [PubMed - as supplied by publisher]
	Prospective Comparison of (64)Copper [(64)Cu]SAR-bisPSMA vs (68)Gallium[(68)Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol Khan S, Papa N, Kneebone A, Eade T, Ayati N, Nguyen A, Wong K, Chen J, Ho B, Idiare J, Sidhom G, Roberts MJ, Thompson J, Sharma S, Weir S, Devitt K, Kooner R, Lieng H, Rasiah K, Olphert J, de Leon J, Hruby G, Stricker P, Emmett L. PMID: 41904043 [PubMed - as supplied by publisher]
	Integrating Multiparametric MRI and PSMA PET Imaging in Prostate Cancer: Toward a Unified Diagnostic and Risk-Stratification Paradigm. Medicina (Kaunas) Pugliesi RA, Cannella R, Ben Mansour K, Di Biagio D, Alongi P. PMID: 41901691 [PubMed - indexed for MEDLINE]
	Comparative Analysis of ISM-1 and B7-H3 Expression in Castration-Resistant Prostate Adenocarcinoma: Associations with Tumor Aggressiveness and Resistance Dynamics. Medicina (Kaunas) Kaya , Öztürk A, Yüceer RO, Öztürk NB. PMID: 41901559 [PubMed - indexed for MEDLINE]
	Improved Anticancer Properties of Silver Nanoparticles by Albumin Coating in Prostate Cancer Cell Lines: An In Vitro Study. Pharmaceutics Zareian Baghdadabad L, Menbari Oskouie I, Yahyazadeh SR, Golmohammadi P, Mashhadi R, Khoshchehreh M, Aghamir SMK. PMID: 41900824 [PubMed]
	The Role of Gut Microbiome in Prostate Cancer: Current Evidence and Emerging Opportunities. Cancers (Basel) Huang J, Zhu XH, Trotman LC, Tsao CK. PMID: 41899599 [PubMed]
	Efficacy and Toxicity in Scheduled Intravesical Gemcitabine Versus Bacillus Calmette-GuÃ©rin for Bladder Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) Kim DK, Jeon J, Kwon JK, Bang S, Lee KS, Koo KC, Cho KS. PMID: 41899592 [PubMed]
	Bladder Preservation with Concurrent Chemoradiotherapy Following Complete Response to Induction Systemic Therapy in Patients with Muscle-Invasive Bladder Cancer: A Review of the Existing Literature. Cancers (Basel) Ntoumas GN, Kougioumtzopoulou A, Desse D, Fragkoulis C, Papadopoulos G, Kostouros E, Michaletou D, Kouloulias V, Zygogianni A, Georgakopoulos I. PMID: 41899563 [PubMed]
	Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and Technologies. Cancers (Basel) Robesti D, Russo P, Fallara G, Blank F, Valerio M, Tewari AK, Montorsi F, Ploussard G, Patil N, Martini A. PMID: 41899547 [PubMed]
	Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer. Cancers (Basel) Lillesand M, Austdal M, Mroz J, Skaland I, Gudlaugsson E, Jong FC, Zuiverloon TCM, Engan K, Janssen EAM. PMID: 41899544 [PubMed]
	Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis. Cancers (Basel) Al-Khanaty A, Santucci J, Hennes D, Sathianathen N, Delgado C, Sharma K, Dinneen E, Sandhu K, Chen D, Eapen R, Moon D, Jack G, Goad J, Siva S, Ali M, Bolton D, Lawrentschuk N, Murphy DG, Perera M. PMID: 41899512 [PubMed]
	Hypoxia-Driven Mechanisms of Drug Resistance in Prostate Cancer. Cancers (Basel) Ressel MR, Flores CE, Warfel NA. PMID: 41899504 [PubMed]
	Novel Immunotherapeutic Strategies for Castration-Resistant Prostate Cancer: Mechanisms and Clinical Advances. Curr Issues Mol Biol Xia X, Xia Z, Yu L. PMID: 41899434 [PubMed]
	Oncofertility in Women with Renal Cell Carcinoma in the Immune Checkpoint Inhibitors Era: A Multidisciplinary Perspective. J Clin Med Miscia M, Raffone A, Mollica V, Piazza P, Cipriani L, Maletta M, Ferla S, Perucci M, Cortese F, Pesaresi I, Pazzaglia E, Cobellis L, Seracchioli R, Raimondo D. PMID: 41899374 [PubMed]

Artikel 1 - 20 / 177121

Seite 1 von 8857

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung